Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1959; 03(02): 279-285DOI: 10.1055/s-0038-1654388 Originalarbeiten — Original Articles — Travaux Originaux Schattauer GmbH Influence of Dicoumarol Derivatives on Plasma Fibrinolytic System Marta Niewiarowska 1 Department of Physiopathology, Institute of Haematology, Warsaw, Poland , Zenon Wegrzynowicz 1 Department of Physiopathology, Institute of Haematology, Warsaw, Poland › Author Affiliations Recommend Article Abstract Full Text PDF Download References References 1 Alexander B, Landwehr G. Evolution of prothrombin conversion accelerator in stored human plasma and prothrombin fractions. Amer. J. Physiol 1949; 159: 332 2 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. Biophys 1952; 40: 346 3 Bachmann F, Duckert F, Geiger H, Baer P, Koller F. Differentiation of factor VII complex. Studies on the Stuart-Prower factor. Thromb. Diath. haem 1957; 1: 169 4 Buluk K, Januszko T. Heparyna a fibrynoliza. Patol. pol 1957; 8: 107 5 Douglas A. S. A mode of action of coumarin drugs. Brit. med. Bull 1955; 11: 39 6 Elsner P. Fibrinolyse in Schwangerschaft und Geburt. Fortschritte der Geburtshilfe und Gynäkologie, Nr. S. Karger, Basel; New York: 1957: 6 7 Halse T. Fibrinolyse. Freiburg (1948), Cantor ed 8 Irish V. V, Jaques L. B. The effect of dicoumarol upon plasma fibrinogen. Amer. J. Physiol 1945; 143: 101 9 Koller F, Loeliger A, Duckert F. Experiments on a new clotting Factor (Factor VII). Acta haemat. (Basel) 1951; 6: 1 10 Koller F. Le Facteur X. Rev. Hémat 1952; 10: 362 11 Kopec M, Niewiarowski S. Czynnosc fibrynolityczna osocza osob zdrowych. Pol. Arch. Med. wewnet 1956; 26: 1322 12 Kowalski E, Latallo Z, Niewiarowski S. Untersuchungen über die Aktivierung von Plasminogen und Inaktivierung von Plasmin. Folia haemat. (Lpz.) 1957; 75: 225 13 Kowarzyk H, Buluk K. Postepy badan nad krzepnieciem krwi. Postepy Medy-cyny Doswiadczalnej i Higieny 1950; 2: 1 14 McElfresh A. E, Özge A. The effect of coumarin drugs upon Plasma Thromboplastin Component. J. Lab. clin. Med 1957; 49: 753 14a Niewiarowska M. L’influence de l’hypothermie par refroidissement sur la coagulation du sang et sur la fibrinolyse chez le chat. Rev. Hémat 1957; 12: 650 15 Niewiarowski S, Latallo Z. unpublished 16 Quick A. J. Hemorrhagic Diseases. Lea and Febiger; Philadelphia: 1957 17 Rechnic M, Siwinska M, Czerwinska B. Antyfibrynolizyna krwi a thrombinogeneza. Arch. Immunol. Ter. Dosw 1957; 5: 347 18 Sise H. S, Kumball D. M, Adams D. Plasma Thromboplastin Component Deficiency produced by prolonged administration of prothrombopenic anticoagulants. Proc. Soc. exp. Biol. (N. Y.) 1955; 89: 91 19 Smith W. B, Rosenfeld R, Shinovara G. Y. Human plasma fibrinogen levels in various pathological states. Fed. Proc 1951; 10: 371 20 Wessler S. Studies on intravascular coagulation, II. A comparison of the effect of dicoumarol and heparin on clot formation in isolated venous segments. J. clin. Invest 1953; 32: 652 21 Witte S. Profibrinolysin, Thrombin-Inhibitor und Antithrombin bei Thrombose und während einer antikoagulierender Therapie. Intern. Tagung über Thrombose und Embolie; Basel: 1954
